elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q58407688-D148A519-D6DC-4872-B1AD-7733EDFD2523
Q58407688-D148A519-D6DC-4872-B1AD-7733EDFD2523
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58407688-D148A519-D6DC-4872-B1AD-7733EDFD2523
Anti-LAG-3 or Urelumab Alone and in Combination With Nivolumab in Treating Patients With Recurrent Glioblastoma
P2899
Q58407688-D148A519-D6DC-4872-B1AD-7733EDFD2523
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58407688-D148A519-D6DC-4872-B1AD-7733EDFD2523
rank
NormalRank
type
BestRank
Statement
P2899
18
http://www.w3.org/2001/XMLSchema#decimal
P2899
8b6345564ae8150994d24178c4c25585